226 related articles for article (PubMed ID: 24708261)
1. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
Kanazawa T; Morisaki K; Suzuki S; Takashima Y
Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
[TBL] [Abstract][Full Text] [Related]
2. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
Kanazawa T; Taki H; Tanaka K; Takashima Y; Okada H
Pharm Res; 2011 Sep; 28(9):2130-9. PubMed ID: 21499835
[TBL] [Abstract][Full Text] [Related]
4. Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.
Taki H; Kanazawa T; Akiyama F; Takashima Y; Okada H
Pharmaceuticals (Basel); 2012 Oct; 5(10):1092-102. PubMed ID: 24281259
[TBL] [Abstract][Full Text] [Related]
5. Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.
Kanazawa T; Taki H; Okada H
Eur J Pharm Biopharm; 2020 Jul; 152():85-94. PubMed ID: 32387702
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
7. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
[TBL] [Abstract][Full Text] [Related]
8. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
[TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis.
Ibaraki H; Hatakeyama N; Arima N; Takeda A; Seta Y; Kanazawa T
Eur J Pharm Biopharm; 2022 Jan; 170():170-178. PubMed ID: 34963657
[TBL] [Abstract][Full Text] [Related]
10. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
[TBL] [Abstract][Full Text] [Related]
13. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles.
Kanazawa T; Kurano T; Ibaraki H; Takashima Y; Suzuki T; Seta Y
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31540164
[TBL] [Abstract][Full Text] [Related]
15. Cell penetrating peptide TAT can kill cancer cells via membrane disruption after attachment of camptothecin.
Song J; Zhang Y; Zhang W; Chen J; Yang X; Ma P; Zhang B; Liu B; Ni J; Wang R
Peptides; 2015 Jan; 63():143-9. PubMed ID: 25496911
[TBL] [Abstract][Full Text] [Related]
16. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
Park EK; Kim SY; Lee SB; Lee YM
J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
18. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
19. Novel polymeric micelles as enzyme-sensitive nuclear-targeted dual-functional drug delivery vehicles for enhanced 9-nitro-20(S)-camptothecin delivery and antitumor efficacy.
Sun Y; Liang Y; Hao N; Fu X; He B; Han S; Cao J; Ma Q; Xu W; Sun Y
Nanoscale; 2020 Mar; 12(9):5380-5396. PubMed ID: 32022069
[TBL] [Abstract][Full Text] [Related]
20. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]